Biomarkers & Immuno-Oncology World Congress
June 11, 2018 - June 13, 2018
Location:
Westin Boston Waterfront
Details:
Hear from ACD at the Biomarkers & Immuno-Oncology World Congress
Learn how the RNAscope™ Assay is expanding CDx strategies.
RNAscope is a clinically validated in situ hybridization assay that enables multiplexed tissue expression analysis in routine clinical biopsy tissues. RNAscope is considered one of the most sensitive and specific platforms for tissue-based expression analysis. It is enabling faster, robust and wide dynamic range tissue-based biomarker expression analysis for accurate correlation to treatment outcome and selection of responsive patient for clinical trial enrollment and CDx.
